This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. NSPR, CTCX, TMDIF, HSAQ, RVP, GBS, PETV, BTCY, IVF, and DYNTShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), GBS (GBS), PetVivo (PETV), Biotricity (BTCY), INVO Fertility (IVF), and Dynatronics (DYNT). These companies are all part of the "medical" sector. Amedica vs. Its Competitors InspireMD Carmell Titan Medical Health Sciences Acquisitions Co. 2 Retractable Technologies GBS PetVivo Biotricity INVO Fertility Dynatronics Amedica (NASDAQ:AMDA) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Does the media favor AMDA or NSPR? In the previous week, InspireMD had 1 more articles in the media than Amedica. MarketBeat recorded 1 mentions for InspireMD and 0 mentions for Amedica. InspireMD's average media sentiment score of 0.95 beat Amedica's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment Amedica Neutral InspireMD Positive Is AMDA or NSPR more profitable? Amedica has a net margin of -139.62% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Amedica-139.62% -148.60% -67.83% InspireMD -413.96%-69.42%-57.68% Which has better valuation & earnings, AMDA or NSPR? Amedica has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Amedica, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedica$11.23M3.48-$9.32M-$3.13-1.05InspireMD$7.07M14.35-$19.92M-$0.83-2.93 Do analysts recommend AMDA or NSPR? InspireMD has a consensus target price of $4.50, indicating a potential upside of 85.19%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in AMDA or NSPR? 3.7% of Amedica shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 0.9% of Amedica shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, AMDA or NSPR? Amedica has a beta of -1.24, suggesting that its share price is 224% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. SummaryInspireMD beats Amedica on 12 of the 16 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.05M$81.58M$5.75B$9.58BDividend YieldN/AN/A4.54%4.09%P/E Ratio-1.0511.0230.3824.94Price / Sales3.48106.70415.42178.09Price / CashN/A18.4137.3459.16Price / Book1.837.428.936.27Net Income-$9.32M-$26.48M$3.26B$265.47M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$3.29+3.5%N/A-28.5%$39.05M$11.23M-1.05N/ANSPRInspireMD4.0041 of 5 stars$2.50flat$4.50+80.0%-14.5%$104.30M$7.07M-3.3350CTCXCarmellN/A$2.40+8.6%N/A+172.2%$50.17M$32.84K0.0014Gap DownTMDIFTitan MedicalN/A$0.37+2.3%N/A+703.0%$42.01M$17.63M-0.2950HSAQHealth Sciences Acquisitions Co. 2N/A$2.66-2.2%N/A-58.8%$29.82MN/A0.004High Trading VolumeRVPRetractable Technologies1.9867 of 5 stars$0.78-3.4%N/A-20.0%$23.20M$33.75M-1.44240News CoverageShort Interest ↑High Trading VolumeGBSGBSN/A$1.51+2.7%N/A+27.8%$22.48MN/A-2.707PETVPetVivoN/A$0.78-4.9%N/A+82.6%$21.60M$1.05M-1.7420Gap DownBTCYBiotricityN/A$0.54flatN/A+34.1%$13.45M$12.06M-0.5040News CoverageGap DownHigh Trading VolumeIVFINVO FertilityN/A$1.75+1.7%N/A-96.2%$1.24M$6.53M-0.0225News CoverageEarnings ReportDYNTDynatronicsN/A$0.09flatN/A-45.5%$1.19M$33.60M-0.11200Gap Up Related Companies and Tools Related Companies InspireMD Competitors Carmell Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors Retractable Technologies Competitors GBS Competitors PetVivo Competitors Biotricity Competitors INVO Fertility Competitors Dynatronics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access